Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0A2OH
|
||||
| Former ID |
DNC013868
|
||||
| Drug Name |
Cudraxanthone L
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530017] | ||
| Formula |
C23H24O6
|
||||
| Canonical SMILES |
CC(=CCC1=C2C(=CC(=C1O)O)C(=O)C3=C(C(=C(C=C3O2)O)C(C)(C)<br />C=C)O)C
|
||||
| InChI |
1S/C23H24O6/c1-6-23(4,5)18-14(24)10-16-17(21(18)28)20(27)13-9-15(25)19(26)12(22(13)29-16)8-7-11(2)3/h6-7,9-10,24-26,28H,1,8H2,2-5H3
|
||||
| InChIKey |
LVKPSBFBKBJJOB-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Neuraminidase | Target Info | Inhibitor | [530017] | |
| KEGG Pathway | Other glycan degradation | ||||
| References | |||||